logo BDSP

Base documentaire

  1. Epidemiology and ethnic aspects of B cell chronic lymphocytic leukemia in Israel.

    Article - En anglais

    Chronic lymphocytic leukemia (CLL) represents 30% of all leukemias in Caucasians.

    In East Europe and USA the disease incidence is high while in Asia and Africa CLL is rare.

    The present study deals with 302 cases of B cell CLL and related disorders ; 207 patients originating from Europe and America (Ashkenazi Jews) and 95 descendants from Asia, The Mediterranean or Africa (Sephardic Jews).

    The patients were recruited during 1975-1996 in a single center covering the Hashfela region - a Southern area of Israel with a current population of 430 000 inhabitants.

    Incidence of the disease, clinical pattern, biological parameters, prognosis and outcome were investigated and compared in both ethnic groups.

    The results of this study show a high incidence of CLL in Israel.

    The mean annual age-adjusted incidence 4.3 per 100000 person-year is among the highest reported values.

    Our study confirms previous data on the prevalence of CLL in Ashkenazi compared to Sephardic Jews.

    The rise in CLL rate in the reviewed period occurred in both populations, mainly in the Sephardic group.

    The relative risk for Ashkenazies compared to Sephardics decreased from 6.0 in the 1975-1979 period to 2.4 in 1990-1996.

    A high rate of CLL was found in new immigrants from the former USSR with 26 cases de novo diagnosed and 11 prevalent cases not included in this series among approximately 60 000 new immigrants in the are over the last 8 years. (...)

    Mots-clés Pascal : Leucémie lymphoïde, Lymphocyte B, Leucémie prolymphocytaire, Origine ethnique, Juif, Incidence, Symptomatologie, Pronostic, Etude comparative, Etude longitudinale, Epidémiologie, Israël, Asie, Homme, Chronique, Hémopathie maligne, Lymphoprolifératif syndrome

    Mots-clés Pascal anglais : Chronic lymphocytic leukemia, B-Lymphocyte, Prolymphocytic leukemia, Ethnic origin, Jew, Incidence, Symptomatology, Prognosis, Comparative study, Follow up study, Epidemiology, Israel, Asia, Human, Chronic, Malignant hemopathy, Lymphoproliferative syndrome

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0522619

    Code Inist : 002B19B. Création : 23/03/1999.